Volume | 1,557,873 |
|
|||||
News | - | ||||||
Day High | 1.04 | Low High |
|||||
Day Low | 0.95 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Vaxart Inc | VXRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.04 | 0.95 | 1.04 | 0.9588 | 1.02 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,103 | 1,557,873 | $ 0.9754882 | $ 1,519,687 | - | 0.53 - 1.54 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:02:38 | 10 | $ 0.9849 | USD |
Vaxart Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
166.91M | 173.86M | - | 7.38M | -82.47M | -0.47 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vaxart News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.7181 | 1.06 | 0.69 | 0.8819323 | 2,530,413 | 0.2669 | 37.17% |
1 Month | 0.82 | 1.06 | 0.6331 | 0.7876597 | 1,587,306 | 0.165 | 20.12% |
3 Months | 1.41 | 1.43 | 0.6331 | 1.03 | 1,612,681 | -0.425 | -30.14% |
6 Months | 0.80 | 1.54 | 0.53 | 0.9812876 | 1,601,861 | 0.185 | 23.13% |
1 Year | 1.27 | 1.54 | 0.53 | 0.9299959 | 1,528,867 | -0.285 | -22.44% |
3 Years | 6.45 | 10.33 | 0.53 | 4.72 | 3,009,512 | -5.47 | -84.73% |
5 Years | 0.72 | 24.90 | 0.2543 | 6.88 | 6,580,195 | 0.265 | 36.81% |
Vaxart Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |